Furthermore, we observed that the gene encoding the selenoprotein TXNRD3 was less expressed in both disease groups (NASH and in steatosis) when compared with HOC, while no significant differences between HC and steatosis samples were observed. The gene discussed is TXNRD3; the disease is metabolic dysfunction-associated steatohepatitis.